Covid-19 roundup: J&J gives deep­est look yet at vac­cine; As­traZeneca shies away from dis­cussing vac­cine com­mer­cial op­por­tu­ni­ty

J&J has giv­en its deep­est look yet in­to its coro­n­avirus vac­cine can­di­date.

The NJ phar­ma and Op­er­a­tion Warp Speed mem­ber

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.